A comparison of the efficacy of Plavix and Osivix in patients undergoing Coronary artery by pass
Phase 3
- Conditions
- Heart disease.Other functional disturbances following cardiac surgery
- Registration Number
- IRCT201112178428N1
- Lead Sponsor
- Research Deputy of Hamadan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
All patients undergoing open heart surgery
Exclusion criteria: 1- Patients with a prior events of acute coronary syndrome, 2- Hepatic insufficiency, 3- History of significant bleeding disorder,4- Those already taking anti-platelet and/or anticoagulant therapy, 5- Age less than 20 and over than 75.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Platelet-rich plasma. Timepoint: 30 days after heart surgery. Method of measurement: Aggregometry.
- Secondary Outcome Measures
Name Time Method Adenosine diphosphate. Timepoint: 30 days after heart surgery. Method of measurement: Aggrigometry.